All-trans-retinoic acid (atRA) is a potent ligand that regulates gene expression and is used to treat several skin disorders. Hyaluronic acid (HA) was previously conjugated with atRA (HA-atRA) to obtain a novel amphiphilic compound. HA-atRA forms micelles that incorporate hydrophobic molecules and facilitate their transport through the skin. The aim of this study was to determine the influence of HA-atRA on gene expression in skin cells and to compare it with that of unbound atRA. Gene expression was investigated using microarrays and a luciferase system with a canonical atRA promoter. HA-atRA upregulated gene expression similarly to atRA. However, HA-atRA activated the expression of cholesterol metabolism genes, unlike atRA. Further investigation using HPLC and filipin III staining suggested that the treated cells induced cholesterol synthesis to replenish the cholesterol removed from the cells by HA-atRA. HA modified with oleate (HA-C18:1) removed cholesterol from the cells similarly to HA-atRA, suggesting that the cholesterol removal stemmed from the amphiphilic nature of the two derivatives. HA-atRA induces retinoid signaling. Thus, HA-atRA could be used to treat skin diseases, such as acne and psoriasis, where the combined action of atRA signaling and anti-inflammatory cholesterol removal may be potentially beneficial.

3rd Faculty of Medicine Charles University 100 00 Prague Czech Republic

Institute of Experimental Biology Faculty of Science Masaryk University 625 00 Brno Czech Republic

International Clinical Research Center St Anne's University Hospital 656 91 Brno Czech Republic

R and D Department Contipro a s 562 04 Dolní Dobrouč Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc22019466

003      

CZ-PrNML

005      

20220804135702.0

007      

ta

008      

220720s2022 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/biom12020200 $2 doi

035    __

$a (PubMed)35204701

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Pavlík, Vojtěch $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic $u Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic $1 https://orcid.org/0000000265759726

245    10

$a Retinoic Acid Grafted to Hyaluronic Acid Activates Retinoid Gene Expression and Removes Cholesterol from Cellular Membranes / $c V. Pavlík, V. Machalová, M. Čepa, R. Šínová, B. Šafránková, J. Kulhánek, T. Drmota, L. Kubala, G. Huerta-Ángeles, V. Velebný, K. Nešporová

520    9_

$a All-trans-retinoic acid (atRA) is a potent ligand that regulates gene expression and is used to treat several skin disorders. Hyaluronic acid (HA) was previously conjugated with atRA (HA-atRA) to obtain a novel amphiphilic compound. HA-atRA forms micelles that incorporate hydrophobic molecules and facilitate their transport through the skin. The aim of this study was to determine the influence of HA-atRA on gene expression in skin cells and to compare it with that of unbound atRA. Gene expression was investigated using microarrays and a luciferase system with a canonical atRA promoter. HA-atRA upregulated gene expression similarly to atRA. However, HA-atRA activated the expression of cholesterol metabolism genes, unlike atRA. Further investigation using HPLC and filipin III staining suggested that the treated cells induced cholesterol synthesis to replenish the cholesterol removed from the cells by HA-atRA. HA modified with oleate (HA-C18:1) removed cholesterol from the cells similarly to HA-atRA, suggesting that the cholesterol removal stemmed from the amphiphilic nature of the two derivatives. HA-atRA induces retinoid signaling. Thus, HA-atRA could be used to treat skin diseases, such as acne and psoriasis, where the combined action of atRA signaling and anti-inflammatory cholesterol removal may be potentially beneficial.

650    _2

$a cholesterol $x metabolismus $7 D002784

650    _2

$a exprese genu $7 D015870

650    _2

$a kyselina hyaluronová $x farmakologie $7 D006820

650    12

$a retinoidy $x farmakologie $7 D012176

650    12

$a tretinoin $x farmakologie $7 D014212

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Machalová, Veronika $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic

700    1_

$a Čepa, Martin $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic

700    1_

$a Šínová, Romana $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic $u Institute of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000272829016

700    1_

$a Šafránková, Barbora $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic

700    1_

$a Kulhánek, Jaromír $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic

700    1_

$a Drmota, Tomáš $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic

700    1_

$a Kubala, Lukáš $u Institute of Experimental Biology, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, 656 91 Brno, Czech Republic $1 https://orcid.org/0000000277297338 $7 xx0094314

700    1_

$a Huerta-Ángeles, Gloria $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic $1 https://orcid.org/0000000281399820

700    1_

$a Velebný, Vladimír $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic

700    1_

$a Nešporová, Kristina $u R&D Department, Contipro, a.s., 562 04 Dolní Dobrouč, Czech Republic $1 https://orcid.org/0000000178647689

773    0_

$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 12, č. 2 (2022)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/35204701 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20220720 $b ABA008

991    __

$a 20220804135656 $b ABA008

999    __

$a ok $b bmc $g 1822884 $s 1170709

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2022 $b 12 $c 2 $e 20220125 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737

LZP    __

$a Pubmed-20220720